Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT03772366
Eligibility Criteria:
Inclusion Criteria E+ :
* Patient in childbearing age and \>18 years
* Venous thromboembolic disease
* Oral anticoagulant treatment (fluindione, warfarine, rivaroxaban ou apixaban)
* Following by vascular doctor of Association Régionale des Médecins Vasculaires (ARMV) PACA (120 doctors) and/or one of the investigator center
* Affiliated with the Social Security Scheme
* Received an oral information
Inclusion Criteria E- :
* Patient in childbearing age and \>18 years
* Superficial venous insufficiency
* No treatment with oral anticoagulant or anti platelet to not interfere with haemorrhage risk
* Following by vascular doctor of Association Régionale des Médecins Vasculaires (ARMV) PACA (120 doctors) and/or one of the investigator center
* Affiliated with the Social Security Scheme
* Received an oral information
* Non opposition register
Exclusion Criteria:
* \<18 years patient
* Woman whose pregnancy is known
* Pre menopause
* Absence of menstruation
* Refusal to participate in the study
* No answer to the second call
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03772366
Study Brief:
Protocol Section:
NCT03772366